Italy · Research startup
Italy · Cellply
Cellply is a DeepTech biotechnology company based in Bologna, Italy, founded in 2013 by Massimo Bocchi and Roberto Guerrieri.
Funding reportedLast round: Undisclosed round
Follow Cellply and see its new rounds in your feed.Start following
About Cellply
Cellply is a DeepTech biotechnology company based in Bologna, Italy, founded in 2013 by Massimo Bocchi and Roberto Guerrieri.
The company focuses on developing advanced analytical tools that characterize the functionality of single immune and tumor cells at a single-cell resolution. Cellply aims to enhance the development of immunotherapies and cell-based therapies by unraveling the complexities of the immune system. The company's flagship product, VivaCyte®, is a fully automated analytical platform that integrates microfluidics, AI-based image analysis, and robotics. This platform supports the development, manufacturing, and quality control of next-generation cell therapies. Cellply also offers services in single-cell potency characterization, in-vitro functional assays, immune cell function profiling, and predictive diagnostics, catering primarily to biopharmaceutical companies, research institutes, and clinicians. With significant funding secured for expansion, Cellply is recognized as an innovative startup in the life sciences sector.
What company datasets say Cellply raised
Funding, as reported
Founders and team
From Cellply's own website: 1 founder, 11 on the team.
- Alex JonesChief Executive Officer
- Alessia ZanelliPresident
- Andrea FaenzaChief Technology Officer
- Priyanka Dutta PasseckerChief Business Officer
- Laura RocchiHead of Biology
- Antonella BeltrameBoard Member
- Carmelo CatalanoBoard Member
- Marco FaddaBusiness Development Manager EMEA/APAC
- Miro VenturiBoard Member
- Paola PoggiOperations & PMO Manager
- Teresa De NadaiBoard Member
On 2 portfolio pages
Investors who name them
Each firm lists Cellply on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
cell characterization platformhealth caresinglecellbiotechnology researchcell therapysingle-cell sample throughputcell function analysissingle-cell analysishospital & health careautomated analysismedicalcell therapy discovery toolshealthbiotechnologypotencycell therapy development
Built with from their website
Google MapsGoogle Tag ManagerWordPress.orgAtlassianViewport MetaVisual ComposerNext.jsGoogle Maps (Non Paid Users)HubspotVimeo
+8 more
GoDaddy DomainswebpackWordpressMicrosoft Exchange OnlinePriority HintsReactCAPTCHAWorkable
- Sector
- Research
- Industry code
- NAICS 541714, 334516, SIC 3824, 8731, 3826
- Region
- Emilia-Romagna
- Revenue
- 7.5M a year, as listed
- Full record
- Every detail in the company directory
Research in Italy
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cellply in front of investors. Or tell us what we have wrong.